The role of prehabilitation in improving brain health and cognition after chemotherapy in patients with colorectal cancer: Study protocol of the Chemo Brain Prehab Project

Hoad, KL ORCID: 0000-0003-1266-3269, Ton, C, Williamson, D, Subar, DA ORCID: 0000-0003-4512-9388, Nuttall, HE and Gaffney, CJ ORCID: 0000-0001-7990-2792 (2026) The role of prehabilitation in improving brain health and cognition after chemotherapy in patients with colorectal cancer: Study protocol of the Chemo Brain Prehab Project. Plos One, 21 (3). pp. 1-18. ISSN 1932-6203

Preview

Text The role of prehabilitation in improving brain health and cognition after chemotherapy in patients with colorectal cancer.pdf - Published Version Available under License Creative Commons Attribution. Download (713kB) | Preview

Abstract

Introduction Regional disparities in the incidence of colorectal cancer remain a concern within the United Kingdom, particularly in the North West of England, with 37% higher incidences than the national average. Given the growing burden of treatment-related side effects such as cognitive impairment, this study aims to investigate whether prehabilitation can improve brain health and cognitive function in patients with colorectal cancer receiving adjuvant and neoadjuvant chemotherapy. Methods This randomised control trial will recruit eighty-six patients with stage II and III colorectal cancer, who will receive adjuvant and neoadjuvant chemotherapy (fluorouracil, capecitabine, or oxaliplatin) and will be randomised between prehabilitation and standard care groups. The prehabilitation group will be provided an individualised, home-based exercise programme before and during chemotherapy, multivitamin supplementation, telephone check-ins, and activity devices. The standard care group will be provided with information about physical activity and nutrition at the start of the intervention. Habitual physical activity will be tracked in all patients. Assessments will be conducted at baseline, 72 hours before the first chemotherapy administration, and 72–96 hours after the final treatment. Outcome measures will include cardiopulmonary fitness, neurotrophic biomarkers, electroencephalographic activity, cognitive function tests, and a cognitive-related quality of life assessment. Discussion This study protocol is designed to test whether home-based prehabilitation can improve brain health and reduce chemotherapy-related cognitive impairments in patients with colorectal cancer. Insights from this work may support the development of more accessible and effective prehabilitation programmes to address treatment specific cognitive impairment.

Item Type:	Article
Uncontrolled Keywords:	Brain; Humans; Colorectal Neoplasms; Chemotherapy, Adjuvant; Neoadjuvant Therapy; Cognition; Quality of Life; Adult; Aged; Middle Aged; Female; Male; Randomized Controlled Trials as Topic; Preoperative Exercise; Humans; Colorectal Neoplasms; Cognition; Female; Male; Quality of Life; Brain; Middle Aged; Aged; Neoadjuvant Therapy; Chemotherapy, Adjuvant; Preoperative Exercise; Adult; Randomized Controlled Trials as Topic; 32 Biomedical and Clinical Sciences; 4203 Health Services and Systems; 4205 Nursing; 4206 Public Health; 42 Health Sciences; 3202 Clinical Sciences; Acquired Cognitive Impairment; Digestive Diseases; Cancer; Behavioral and Social Science; Prevention; Clinical Trials and Supportive Activities; Neurodegenerative; Colo-Rectal Cancer; Clinical Research; Brain Disorders; Neurosciences; Physical Activity; Cancer; 3 Good Health and Well Being; Humans; Colorectal Neoplasms; Cognition; Female; Male; Quality of Life; Brain; Middle Aged; Aged; Neoadjuvant Therapy; Chemotherapy, Adjuvant; Preoperative Exercise; Adult; Randomized Controlled Trials as Topic; 32 Biomedical and Clinical Sciences; 4203 Health Services and Systems; 4205 Nursing; 4206 Public Health; 42 Health Sciences; Physical Activity; Neurodegenerative; Cancer; Colo-Rectal Cancer; Clinical Trials and Supportive Activities; Brain Disorders; Prevention; Neurosciences; Acquired Cognitive Impairment; Clinical Research; Digestive Diseases; Behavioral and Social Science; 6.1 Pharmaceuticals; Cancer; 3 Good Health and Well Being; General Science & Technology
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry R Medicine > RM Therapeutics. Pharmacology
Divisions:	Sport and Exercise Sciences
Publisher:	Public Library of Science (PLoS)
Date of acceptance:	4 February 2026
Date of first compliant Open Access:	16 March 2026
Date Deposited:	16 Mar 2026 15:51
Last Modified:	16 Mar 2026 15:51
DOI or ID number:	10.1371/journal.pone.0341996
Editors:	Torrado Pacheco, A
URI:	https://researchonline.ljmu.ac.uk/id/eprint/28257

View Item